Drugs / Astressin 2B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01049542 | May → Jul 2010 | heart disorder, vascular disorder | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astressin 2B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01049542 ↗ |
| Action | Inhibit | “Astressin 2B (a selective and potent Urocortin 2 & 3 antagonist)” NCT01049542 ↗ |